MPM Bioimpact
MPM Bioimpact is a private equity and venture manager in Boston, MA. It is registered with the SEC as an investment adviser with $3.6B in regulatory assets and 50 staff. It has 2 funds on file, the latest reported in June 2023.
Funds on file
2
Raised, all funds
$677.8M
Regulatory assets
$3.6B
Staff
50
Pension investors
None found
See the adviser's own filing →
Latest fund filing
Funds
DateFundTypeRaisedTarget
Adviser record
RegistrationRegistered with the SEC as an investment adviser.
Regulatory assets$3.6B
Employees50
Clients23 private funds.
Control personsChristiana, Goh Bardon, Todd, Thomas Foley, Brendan, Michael Furey, Ansbert, Karl Gadicke, Kristen, Lee Laguerre, Robert, Samuel Risoleo.
Private funds21 private funds holding $3.3B in gross assets.
Private funds it reports
FundTypeGross assets
Ubs Oncology Impact Fund
Other
$721M
MPM Bioventures 2018
Venture
$652.6M
MPM Oncology Innovations Fund
Venture
$169.9M
Bioimpact Equities Fund
Hedge fund
$153.9M
MPM Bioventures 2014
Venture
$147.7M
Bioimpact Equities Master Fund
Hedge fund
$99M
MPM Bioventures Iv-qp
Venture
$52.5M
MPM Bioventures 2018 (B)
Venture
$33.9M
MPM Bioventures V
Venture
$20.4M
MPM Asset Management Investors BV2018
Venture
$13.6M
MPM Bioventures 2014 (B)
Venture
$9.7M
MPM Bio IV NVS Strategic Fund
Venture
$7.3M
MPM Bio 2014 NVS Strategic Fund
Venture
$7.2M